Meeting
2022 ASCO Annual Meeting
Questioning a Li-Fraumeni Syndrome diagnosis: Characterization of a commonly observed germline TP53 variant, p.Arg156His.
Authors
Bita Nehoray
City of Hope, Duarte, CA
Bita Nehoray , Alison Schwartz , Sophie Hyman , Samantha Stokes , Aleck Cervantes , Christopher Amos , Stephen B. Gruber , Judy Ellen Garber
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10612)
DOI
10.1200/JCO.2022.40.16_suppl.10612
Abstract #
10612
Poster Bd #
486
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.
First Author: Helen Mackay
Poster
2022 ASCO Genitourinary Cancers Symposium
Evaluation of ctDNA alterations in mCRPC patients with germline pathogenic mutations.
First Author: Malcolm Light
Poster
2020 ASCO Virtual Scientific Program
Clinical conundrums: Developing a strategy for discerning TP53-associated chip and coherent clinical care.
First Author: Jeffrey N. Weitzel
Poster
2018 ASCO Annual Meeting
Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing.
First Author: Sarah A. Jackson